Search
Burosumab
go.drugbank.com/drugs/DB14012ApprovedInvestigationalBurosumab (KRN23) is an entirely human monoclonal IgG1 antibody that binds excess fibroblast growth factor 23 (FGF23) and has been successfully tested in clinical trials in children with X-linked hypophosphatemic … This is the first drug approved to treat adults and children ages 1 year and older with X-linked hypophosphatemia (XLH), which is a rare, inherited form of rickets.
Products: CRYSVITA ® SOLUCION PARA INYECCIÓN 10MG/ML, CRYSVITA® SOLUCIÓN PARA INYECCIÓN 20 MG/MLImdevimab
go.drugbank.com/drugs/DB15940ApprovedInvestigational[A224429] These antibodies have been formulated to bind to multiple locations on the SARS-COV-2 spike protein, preventing viral escape. … [L23539] This drug is a combination of antibodies derived from humanized VelocImmune® mice in addition to blood samples from patients who have recovered from COVID-19.
Tyrothricin
go.drugbank.com/drugs/DB13503ApprovedWithdrawnMoreover, tyrothricin possesses broad spectrum Gram-positive antibacterial and antifungal activity that has not seen many - if any - significant reportings of microbial resistance during the over 60 years … and 40% neutral linear gramicidins (where valine-gramicidin A is often the major gramicidin present, although the mixture composition can vary) [L4019, L4021, L4022].
Lurbinectedin
go.drugbank.com/drugs/DB12674ApprovedInvestigationalLurbinectedin is a DNA alkylating agent that has been investigated in the treatment of a variety of cancers, including mesothelioma,[A214325] chronic lymphocytic leukemia (CLL),[A214328] breast cancer, … the substitution of the tetrahydroisoquinoline with a tetrahydro β‐carboline that results in increased antitumour activity of lurbinectedin as compared to its predecessor.
Categories: Cytochrome P-450 Substrates, P-glycoprotein inhibitorsGolimumab
go.drugbank.com/drugs/DB06674ApprovedInvestigationalAdditionally in children and adolescents taking golimumab, there have been lymphoma and other malignancies observed. … In the U.S. and Canada, golimumab is marketed under the brand name Simponi®. The FDA label includes a black box warning of serious infections and malignancy.
Categories: Tumor Necrosis Factor Receptor Blocking ActivityProducts: SIMPONI 50MG ILO I E FER, SIMPONI® IVSalsalate
go.drugbank.com/drugs/DB01399ApprovedInvestigationalThe usefulness of salicylic acid, the active in vivo product of salsalate, in the treatment of arthritic disorders has been established. … Salsalate is a nonsteroidal anti-inflammatory agent for oral administration.
Synonyms: 2-Carboxyphenyl salicylate, o-Salicylsalicylic acidCategories: Non COX-2 selective NSAIDSOctreotide
go.drugbank.com/drugs/DB00104ApprovedInvestigational[L14513] In the past, octreotide has been administered solely by injection. … Acromegaly is a life-threatening disease requiring life-long management.
Categories: Somatostatin Receptor Agonists, P-glycoprotein substratesProducts: SANDOSTATIN VIALES PARA DOSIS MULTIPLE 1 MG/ 5 ML, SANDOSTATIN® LAR® 30 MG MICROESFERAS PARA INYECCIONSamidorphan
go.drugbank.com/drugs/DB12543ApprovedInvestigational[A235638, A235643] Samidorphan is a novel opioid antagonist structurally related to [naltrexone], with a higher affinity for opioid receptors, more potent μ-opioid receptor antagonism, higher oral bioavailability … Samidorphan has been shown in animal models and clinical trials to ameliorate [olanzapine]-induced weight gain and metabolic dysfunction.
Salts: Samidorphan L-malateCategories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A SubstratesSodium-dependent phosphate transporter 1
go.drugbank.com/bio_entities/BE0005055TransporterHumansSodium-phosphate symporter which preferentially transports the monovalent form of phosphate with a stoichiometry of two sodium ions per phosphate ion (PubMed:11009570, PubMed:16790504, PubMed:17494632, PubMed:19726692, PubMed:7929240, Pu...
Synonyms: Leukemia virus receptor 1 homolog, Gibbon ape leukemia virus receptor 1Platelet glycoprotein 4
go.drugbank.com/bio_entities/BE0010538TargetTransporterHumansMultifunctional glycoprotein that acts as a receptor for a broad range of ligands. … Receptor for thrombospondins, THBS1 and THBS2, mediating their antiangiogenic effects (By similarity).
Synonyms: Thrombospondin receptor, Platelet collagen receptor